News Releases

Return to News

Feature Story


OHC Announces New Location, New Oncologist

OHC, News Releases, 2 comments
May 1, 2018



Lesia Golden
OHC Marketing Department
513-751-2273 ext. 10204

Portrait photo of Dr Basel S Yanes medical oncologist with OHC

Basel S. Yanes, MD
Medical Oncologist with OHC

Cincinnati, May. 1, 2018 — OHC, the region’s premier source of treatment for nearly every form of adult cancer and complex blood disorder, is pleased to announce that Basel S. Yanes, MD, has joined OHC. Dr. Yanes will see patients at OHC’s new location in Dayton, 400 Sugar Camp Circle, Suite 200, Oakwood, Ohio 45409.

Dr. Yanes received his medical degree from the University of Damascus, Syria. He completed his residency at Miami Valley Hospital in Dayton, Ohio, and a fellowship in medical oncology and hematology at The Ohio State University. Dr. Yanes is board certified in internal medicine and hematology by the American Board of Internal Medicine. He specializes in hematology and breast cancer.

Dr. Yanes is a member of numerous professional associations including the American Medical Association, the American Society of Hematology, the American Society of Clinical Oncology (ASCO) and the American College of Physicians. He is a Clinical Professor of Medicine at Wright State University in Dayton, Ohio.

Dr. Yanes has been a principle investigator of many clinical research trials and has presented the results of his research at national and international cancer and blood disorder conferences. He has had numerous publications in the field of hematology and oncology and has been active in many professional and community organizations, including serving as a Board Member for the American Cancer Society, Hospice of Dayton, and the Leukemia & Lymphoma Society. He has also served on community and national boards including the Dayton Art Institute, National Council for Community Justice, and Builders for Peace.

In his free time, Dr. Yanes enjoys reading, the arts, and sports. He loves reading about history and current events, visual and performing arts, and he is a collector of glass art. Dr. Yanes is a fan of Real Madrid Soccer and Ohio State football.

Joining Dr. Yanes at the new location will be Joseph See, M.D., a board certified medical oncologist with OHC.

Dr. See earned his bachelor’s degree from Xavier University in Cincinnati. He earned his medical degree, completed his residency training in Internal Medicine and fellowship training in at Wright State University Boonshoft School of Medicine in Dayton. He is board certified by the American Board of Internal Medicine and a member of the American College of Physicians and American Society of Clinical Oncology.

Growing up in a family that embraced the philosophy of helping others and a love of science inspired Dr. See to become a doctor. But it was the special patient-doctor relationship that encouraged him to specialize in oncology and hematology.

“At the beginning of my career, I was a hospitalist, caring for a high volume of patients from all ages and specialties. I loved working with the patients and coordinating their plan of care,” explained Dr. See. “One day, I shadowed a local oncologist and was amazed by the patient-doctor interaction I witnessed — it was a deep and trusting relationship. Oncologists deliver very personal care and this relational aspect of medical treatment helps patients during their struggle to overcome the disease.”

As a hematologist/oncologist, he believes in empathizing with his patients and being an advocate of strength and hope to them. He also listens and cultivates lasting relationships with his patients and their families.

For more information or to schedule an appointment with Dr. Yanes or Dr. See, please call 937-262-7819 or visit ohcare.com.

At OHC, the search for new treatments is relentless, the drive to provide superior care runs deep and the fight against cancer is personal. As one of the nation’s largest independent oncology practices, OHC has renowned experts who aggressively attack cancer with every possible strategy; an in-house, nationally-recognized clinical trials program engaged in a passionate search for innovative treatment options; and counselors and navigators to help patients understand their disease, manage finances and gain power over cancer’s impact on their life. Learn more at ohcare.com and follow us on Facebook.



Leave a Reply

Your email address will not be published. Required fields are marked *

2 Responses

  1. Bill Clegern says:

    I am being treated now at OHC Mercy West for duedonal adenocarcinoma with oxiplatin and Xolara and atavistine. A remission has failed so I am wondering if a new trial will begin soon and how I can sign up as a participant. My oncologist, Dr Kurt P. Louenberger, has done testing and found I was not a match two months ago.